SRT Therapeutics
PrivateLast Round
Seed
Aug 1, 2025
Total Funding Raised
$47.4M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
SRT Therapeutics is a biotechnology company that develops precision medicine therapies targeting inflammatory pathways and tissue healing for inflammatory bowel disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SRT Therapeutics Comparables
Compare SRT Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Radionetics Oncology | 86% | |
| Abdera Therapeutics | 85% | |
| Alpha-9 Oncology | 84% |
SRT Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 1, 2025 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 24, 2026
Grew 16% QoQ, from 25 to 29 employees.
- Aug 28, 2026
Grew 18% QoQ from 22 to 26 employees.
SRT Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SRT Therapeutics's valuation, stock price, and market status.
Is SRT Therapeutics a public or private company?
SRT Therapeutics is a private company.
What is the current stock price of SRT Therapeutics?
SRT Therapeutics is a private company, so its shares have no public market price. Caplight tracks SRT Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SRT Therapeutics worth (valuation)?
Valuation information for SRT Therapeutics is not publicly available.
Can I buy SRT Therapeutics stock?
SRT Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SRT Therapeutics's last funding round?
SRT Therapeutics's most recent funding round was Seed on August 1, 2025.
Who are the main investors in SRT Therapeutics?
Investor information for SRT Therapeutics is not publicly disclosed.
Will SRT Therapeutics IPO soon?
No public IPO plans have been announced for SRT Therapeutics.
How can I track SRT Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in SRT Therapeutics's shares on secondary markets.